This is a national, multicentre, prospective, open, two-arm, non-interventional study with hospitalized patients, who are treated routinely with cafedrine/theodrenaline or ephedrine after occurrence of perioperative hypotension, wherein the patients are assigned to a treatment arm based on the department.
Study Type
OBSERVATIONAL
Enrollment
2,013
The incidence of newly occurring HR ≥ 100 beats/min
Time frame: during the first 15 minutes after initial drug administration of cafedrine/theodrenaline or ephedrine
Weighted deviation below the individually determined, lowest systolic blood pressure BPmin
Time frame: within the first 15 minutes after the initial delivery of the antihypotonic drug as area1 (AUC) between the systolic blood pressure curve (below BPmin) and the lower limit BPmin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Teva Investigational Site 133
Aachen, Germany
Teva Investigational Site 122
Amberg, Germany
Teva Investigational Site 106
Aue, Germany
Teva Investigational Site 116
Augsburg, Germany
Teva Investigational Site 165
Aurich, Germany
Teva Investigational Site 110
Bad Hersfeld, Germany
Teva Investigational Site 134
Bad Saarow, Germany
Teva Investigational Site 174
Bad Soden, Germany
Teva Investigational Site 142
Baden-Baden, Germany
Teva Investigational Site 121
Brake, Germany
...and 65 more locations